Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
Junji
J
Ikewaki
Masao
M
Ogata
Tomoyuki
T
Imamura
Kazuhiro
K
Kohno
Toshiyuki
T
Nakayama
Jun-Ichi
J
Kadota
D000368:Aged; D000641:Ammonia / Q000097:blood; D001928:Brain Diseases, Metabolic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D009360:Neoplastic Cells, Circulating / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
D000641:Ammonia